MX2007008506A - Metodos y productos para genotipificacion in vitro. - Google Patents
Metodos y productos para genotipificacion in vitro.Info
- Publication number
- MX2007008506A MX2007008506A MX2007008506A MX2007008506A MX2007008506A MX 2007008506 A MX2007008506 A MX 2007008506A MX 2007008506 A MX2007008506 A MX 2007008506A MX 2007008506 A MX2007008506 A MX 2007008506A MX 2007008506 A MX2007008506 A MX 2007008506A
- Authority
- MX
- Mexico
- Prior art keywords
- products
- methods
- vitro
- genotyping
- vitro genotyping
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000003205 genotyping method Methods 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 230000007614 genetic variation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200500089 | 2005-01-13 | ||
| ES200502423A ES2326708B1 (es) | 2005-10-05 | 2005-10-05 | Metodos y productos para genotipado in vitro. |
| US75819206P | 2006-01-12 | 2006-01-12 | |
| PCT/IB2006/000796 WO2006075254A2 (en) | 2005-01-13 | 2006-01-12 | Methods and products for in vitro genotyping |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007008506A true MX2007008506A (es) | 2010-05-17 |
Family
ID=36677993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007008506A MX2007008506A (es) | 2005-01-13 | 2006-01-12 | Metodos y productos para genotipificacion in vitro. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7914990B2 (enExample) |
| EP (1) | EP1836322B8 (enExample) |
| JP (1) | JP2008526249A (enExample) |
| AU (1) | AU2006205571B2 (enExample) |
| CA (1) | CA2594730A1 (enExample) |
| MX (1) | MX2007008506A (enExample) |
| WO (1) | WO2006075254A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8688385B2 (en) * | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
| WO2004074456A2 (en) | 2003-02-20 | 2004-09-02 | Mayo Foundation For Medical Education And Research | Methods for selecting medications |
| US8153363B2 (en) | 2005-01-13 | 2012-04-10 | Progenika Biopharma S.A. | Methods and products for in vitro genotyping |
| EP1958111A4 (en) | 2005-11-29 | 2009-07-08 | Childrens Hosp Medical Center | OPTIMIZATION AND INDIVIDUALIZATION OF THE SELECTION AND DOSAGE OF MEDICAMENTS |
| GB0613844D0 (en) | 2006-07-12 | 2006-08-23 | Progenika Biopharma Sa | Methods and products for in vitro genotyping |
| CN102154274A (zh) * | 2006-11-30 | 2011-08-17 | 爱科来株式会社 | Nat2基因扩增用引物对、含有其的nat2基因扩增用试剂及其用途 |
| EP2055776A4 (en) | 2006-11-30 | 2009-11-25 | Arkray Inc | PRIMER ASSEMBLY FOR OBESITY GENE AMPLIFICATION, REAGENT FOR OBESITY GENE AMPLIFICATION COMPRISING THE PRIMER ASSEMBLY AND USE THEREOF |
| WO2008066163A1 (en) * | 2006-11-30 | 2008-06-05 | Arkray, Inc. | Primer set for amplification of cyp2c9 gene, reagent for amplification of cyp2c9 gene comprising the same, and use of the same |
| ITMI20070504A1 (it) * | 2007-03-13 | 2008-09-14 | Fond Irccs Ospedale Maggiore | Metodo per la tipizzazione genomica di sistemi eritrocitari, sonde oligonucleotidiche e kit diagnostici relativi |
| JP4410269B2 (ja) * | 2007-03-28 | 2010-02-03 | 株式会社東芝 | Ｎ−アセチルトランスフェラーゼ２（ｎａｔ２）の遺伝子型を検出するための核酸プライマーセット、キット、及び該プライマーセットを用いた検出方法 |
| EP2173896A2 (en) * | 2007-06-29 | 2010-04-14 | Biomonitor A/S | Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| JP5290957B2 (ja) * | 2007-10-09 | 2013-09-18 | アークレイ株式会社 | 免疫関連遺伝子の多型の検出用プローブおよびその用途 |
| JP2011520425A (ja) * | 2008-04-18 | 2011-07-21 | ザ ユニバーシティー オブ テネシー リサーチ ファウンデーション | 一塩基多型（ｓｎｐ）および免疫寛容の誘導に対する耐性との関連 |
| WO2009130797A1 (ja) * | 2008-04-22 | 2009-10-29 | 東洋鋼鈑株式会社 | Abo式血液型を判定するためのプローブセット |
| WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| WO2010075579A2 (en) * | 2008-12-24 | 2010-07-01 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy |
| EP2406396A2 (en) | 2009-03-12 | 2012-01-18 | Brainco Biopharma, S.L. | A genotyping tool for improving the prognostic and clinical management of ms patients |
| WO2011027218A1 (en) * | 2009-09-04 | 2011-03-10 | Progenika Biopharma, S.A. | High throughput detection of genomic copy number variations |
| US9677125B2 (en) * | 2009-10-21 | 2017-06-13 | General Electric Company | Detection of plurality of targets in biological samples |
| US9558320B2 (en) * | 2009-10-26 | 2017-01-31 | Genomas, Inc. | Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants |
| US20130085081A1 (en) * | 2010-06-08 | 2013-04-04 | National Cancer Center | Risk prediction of developing drug-induced lung injury and detection method and kit of gene for risk prediction |
| EP2397561B1 (en) | 2010-06-18 | 2017-08-02 | Progenika Biopharma, S.A. | Methods for determining the presence or absence of genetic segments |
| US8766034B2 (en) | 2010-09-22 | 2014-07-01 | Cedars-Sinai Medical Center | TL1A model of inflammation fibrosis and autoimmunity |
| ES2445709T3 (es) * | 2010-12-31 | 2014-03-04 | Progenika Biopharma, S.A. | Método para la identificación por técnicas moleculares de variantes genéticas que no codifican antígeno D (D-) y codifican antígeno C alterado (C+W) |
| EP2497835B1 (en) * | 2011-03-09 | 2015-08-12 | ARKRAY, Inc. | Probe for detecting polymorphism in CYP3A gene, method of detecting polymorphism, method of evaluating drug efficacy, and reagent kit for detecting polymorphism |
| EP2535424B1 (en) * | 2011-06-16 | 2015-08-05 | Gendiag.exe, S.L. | SNPs associated with thromboemoblic disease |
| US10557170B2 (en) | 2011-06-16 | 2020-02-11 | Gendiag.Exe, S.L. | Thromboembolic disease markers |
| WO2012171990A1 (en) * | 2011-06-17 | 2012-12-20 | Progenika Biopharma, S.A. | Discrimination of blood type variants |
| AR088867A1 (es) * | 2011-11-15 | 2014-07-16 | Acgt Intellectual Ltd | Metodo y aparato para detectar variacion(es) del acido nucleico |
| EP2596806A1 (en) * | 2011-11-25 | 2013-05-29 | Index Pharmaceuticals AB | Method for prevention of colectomy |
| WO2013107005A1 (zh) * | 2012-01-18 | 2013-07-25 | 上海市血液中心 | 人稀有血型的多重pcr检测方法和试剂盒 |
| JP6028300B2 (ja) * | 2012-08-31 | 2016-11-16 | 東洋鋼鈑株式会社 | Ａｂｏ式血液型を判定するためのプライマーセット及びプローブ |
| US20140274763A1 (en) * | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to pain treatments |
| KR20230109779A (ko) | 2013-03-27 | 2023-07-20 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전 |
| EP4105236A1 (en) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease |
| JP2015128399A (ja) * | 2014-01-09 | 2015-07-16 | 東洋紡株式会社 | Ｃｙｐ３ａ５の検出方法 |
| KR20180127416A (ko) | 2016-03-17 | 2018-11-28 | 세다르스-신나이 메디칼 센터 | Rnaset2를 통한 염증성 장 질환의 진단 방법 |
| US11699069B2 (en) * | 2017-07-13 | 2023-07-11 | Helix, Inc. | Predictive assignments that relate to genetic information and leverage machine learning models |
| EP3679060A1 (en) * | 2017-09-07 | 2020-07-15 | Regeneron Pharmaceuticals, Inc. | Solute carrier family 14 member 1 (slc14a1) variants and uses thereof |
| WO2019075577A1 (en) | 2017-10-20 | 2019-04-25 | The Governors Of The University Of Alberta | Mononucleotide Polymorphisms and Feed Efficacy in Livestock |
| JP6995604B2 (ja) * | 2017-12-15 | 2022-01-14 | 東洋鋼鈑株式会社 | 一塩基多型検出用プローブの設計方法及びプローブセット |
| CN112602153A (zh) * | 2018-08-30 | 2021-04-02 | 生命科技股份有限公司 | 用于对pcr测定进行基因分型的机器学习系统 |
| WO2021162028A1 (ja) * | 2020-02-14 | 2021-08-19 | 東レ株式会社 | バイオチップの製造方法 |
| CN112442532B (zh) * | 2020-08-27 | 2023-09-26 | 深圳市卫生健康发展研究中心 | 同时检测20种葡萄糖-6-磷酸脱氢酶缺乏症的引物组及试剂盒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1165839A2 (en) * | 1999-03-26 | 2002-01-02 | Whitehead Institute For Biomedical Research | Universal arrays |
| WO2001029268A2 (en) | 1999-10-18 | 2001-04-26 | Curagen Corporation | Method for identifying interacting gene products |
| AU784861B2 (en) * | 1999-10-21 | 2006-07-06 | Case Western Reserve University | Gene expression profiling of inflammatory bowel disease |
| AU2003247832A1 (en) * | 2002-06-28 | 2004-01-19 | Applera Corporation | A system and method for snp genotype clustering |
-
2006
- 2006-01-12 CA CA002594730A patent/CA2594730A1/en not_active Abandoned
- 2006-01-12 US US11/813,646 patent/US7914990B2/en active Active
- 2006-01-12 MX MX2007008506A patent/MX2007008506A/es active IP Right Grant
- 2006-01-12 JP JP2007550872A patent/JP2008526249A/ja active Pending
- 2006-01-12 EP EP06727428.2A patent/EP1836322B8/en not_active Expired - Lifetime
- 2006-01-12 AU AU2006205571A patent/AU2006205571B2/en not_active Ceased
- 2006-01-12 WO PCT/IB2006/000796 patent/WO2006075254A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1836322B8 (en) | 2017-01-11 |
| CA2594730A1 (en) | 2006-07-20 |
| EP1836322B1 (en) | 2016-09-07 |
| WO2006075254A3 (en) | 2007-03-22 |
| AU2006205571B2 (en) | 2012-03-22 |
| EP1836322A2 (en) | 2007-09-26 |
| AU2006205571A1 (en) | 2006-07-20 |
| JP2008526249A (ja) | 2008-07-24 |
| WO2006075254A2 (en) | 2006-07-20 |
| US20080070253A1 (en) | 2008-03-20 |
| US7914990B2 (en) | 2011-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006075254A3 (en) | Methods and products for in vitro genotyping | |
| CA111398S (en) | Bottle | |
| CA111399S (en) | Bottle | |
| TWI315946B (en) | Codebook generation system and associated methods | |
| CA121621S (en) | Bottle | |
| CA117315S (en) | Container | |
| CA111400S (en) | Bottle | |
| GB2435590A (en) | An interleaver and associated methods | |
| WO2006044754A3 (en) | Process for preparing telmisartan | |
| MX2007007613A (es) | Formulaciones farmaceuticas. | |
| EP1931563A4 (en) | RESISTANCE, DRIVE AND DRIVE GENERATION SYSTEM | |
| TW200630348A (en) | Tadalafil crystal forms and processes for preparing them | |
| CA114740S (en) | Hair trimmer | |
| CA118651S (en) | Open-mouth container | |
| TW200635934A (en) | Amorphous tacrolimus and preparation thereof | |
| ZA200704751B (en) | Fluidizing base, method for the production thereof and associated fluidizing device | |
| CA116344S (en) | Container for chewing gum | |
| CA107584S (en) | Jar | |
| AU305008S (en) | Shelving | |
| AU306757S (en) | Buffet | |
| AU303091S (en) | Moove bottle shape | |
| CA122991S (en) | Bottle | |
| CA121619S (en) | Bottle | |
| AU300903S (en) | Dining set | |
| CA120369S (en) | Display apparatus for eyewear |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |